Seniors Have Eyes, Ears, and Teeth Act

Medicare: Medicare Dental Benefit Act of 2019 (HR 2951/S. 22); Seniors Have Eyes, Ears, and Teeth Act (HR 576); Medicare Dental, Vision and Hearing Benefit Act of 2019 (HR 1393); Medicare Dental Act of 2019 (HR 4650). Medicaid: Medicaid funding; H.R. 748 - Coronavirus Aid, Relief and Economic Security Act; H.R.133 - Consolidated Appropriations Act, 2021. A regulatory proposal to end the maintenance of effort requirements on supplemental benefits for state Medicaid programs and a proposal regarding periodic reviews and expiration of HHS regulation.

Client expense: $110,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE

Medicare Coverage of Dental Care: H.R. 576 and S. 22, Negotiation of Prescription Drug Prices: S. 99 and H.R. 448 and S. 62 and H.R. 275, Prescription Drug Importation: H.R. 447 and S. 97 and S. 61, Improving Access to Affordable Generics: S. 64. SS Immunization Act: H.R. 5076

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare: Medicare Dental Benefit Act of 2019 (HR 2951/S. 22); Seniors Have Eyes, Ears, and Teeth Act (HR 576); Medicare Dental, Vision and Hearing Benefit Act of 2019 (HR 1393); Medicare Dental Act of 2019 (HR 4650). Medicaid: Medicaid funding; H.R. 748 - Coronavirus Aid, Relief and Economic Security Act.

Client expense: $100,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, Small Business Administration (SBA)

Policies related to an increase in the Federal Medical Assistance Percentage (FMAP) under section 1905(b) of the Social Security Act, and related to an FMAP increase for dental services; Medicare and Medicaid Dental, Vision, and Hearing Benefit Act of 2019 (S. 1423); Seniors Have Eyes, Ears, and Teeth Act (H.R. 576); Medicare Dental Benefit Act of 2019 (S. 22/H.R. 2951); Medicare Dental, Vision, and Hearing Benefit Act of 2019 (H.R. 1393); Medicare Dental Act of 2019 (H.R. 4650); Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3).

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Policies related to an increase in the Federal Medical Assistance Percentage (FMAP) under section 1905(b) of the Social Security Act, and related to an FMAP increase for dental services; Medicare Dental Benefit Act of 2019 (HR 2951/S 22), Seniors Have Eyes ,Ears, and Teeth Act (HR 576); Medicare Dental, Vision and Hearing Benefit Act of 2019 (HR 1393); Medicare Dental Act of 2019 (HR 4650).

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 1393, Medicare Dental, Vision, and Hearing Benefit Act, 2019. H.R. 576, Seniors Have Eyes, Ears, and Teeth Act, 2019.

Client expense: $300,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Coverage of Dental Care: H.R. 576 and S. 22, Negotiation of Prescription Drug Prices: S. 99 and H.R. 448 and S. 62 and H.R. 275, Prescription Drug Importation: H.R. 447 and S. 97 and S. 61, Improving Access to Affordable Generics: S. 64. SS Immunization Act: H.R. 5076

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare: Medicare Dental Benefit Act of 2019 (HR 2951/S. 22); Seniors Have Eyes, Ears, and Teeth Act (HR 576); Medicare Dental, Vision and Hearing Benefit Act of 2019 (HR 1393); Medicare Dental Act of 2019 (HR 4650). Medicaid: Medicaid funding; H.R. 748 - Coronavirus Aid, Relief and Economic Security Act

Client expense: $90,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Small Business Administration (SBA)

H.R. 1393, Medicare Dental, Vision, and Hearing Benefit Act, 2019. H.R. 576, Seniors Have Eyes, Ears, and Teeth Act, 2019.

Client expense: $330,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Coverage of Dental Care: H.R. 576 and S. 22, Negotiation of Prescription Drug Prices: S. 99 and H.R. 448 and S. 62 and H.R. 275, Prescription Drug Importation: H.R. 447 and S. 97 and S. 61, Improving Access to Affordable Generics: S. 64. SS Immunization Act: H.R. 5076

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Dental Benefit Act of 2019 (HR 2951/S. 22); Seniors Have Eyes, Ears, and Teeth Act (HR 576); Medicare Dental, Vision and Hearing Benefit Act of 2019 (HR 1393); Medicare Dental Act of 2019 (HR 4650)

Client expense: $100,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicare and Medicaid Dental, Vision, and Hearing Benefit Act of 2019 (S. 1423); Seniors Have Eyes, Ears, and Teeth Act (H.R. 576); Medicare Dental Benefit Act of 2019 (S. 22/H.R. 2951); Medicare Dental, Vision, and Hearing Benefit Act of 2019 (H.R. 1393); Medicare Dental Act of 2019 (H.R. 4650); Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3).

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 3 Lower Drug Costs Now Act of 2019 -allowing Medicare to negotiate prescription drug prices, limiting the ability of drug companies to spike their prices overnight, ensuring that actions to address egregious prices apply to coverage beyond Medicare S. 2543 Prescription Drug Pricing Reduction Act of 2019 - comprehensive legislation to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers HR 6159 Kids' Access to Primary Care Act of 2020 - To amend title XIX of the Social Security Act to renew the application of the Medicare payment rate floor to primary care services furnished under the Medicaid program, and for other purposes. H.R.1393 Medicare Dental, Vision, and Hearing Benefit Act of 2019 - provide for coverage of dental, vision, and hearing care under the Medicare program. H.R.576 Seniors Have Eyes, Ears, and Teeth Act - expands Medicare coverage to include eyeglasses, hearing aids, and dental care. S.22/H.R.2951 Medicare Dental Benefit Act of 2019 - coverage of dental services under Medicare Part B H.R.1342 EMPOWER Care Act - reauthorize the Money Follows the Person Demonstration Program H.R. 1343 - Protecting Married Seniors Act - provisions regarding Medicaid eligibility that protect against spousal impoverishment for recipients of home and community-based services. H.R. 4996 Helping Medicaid Offer Maternity Services Act of 2019 - MOMs Act - provide for a State option under the Medicaid program to provide for and extend continuous coverage for certain individual S.1423Medicare and Medicaid Dental, Vision, and Hearing Benefit Act of 2019 - provide for coverage of dental, vision, and hearing care under the Medicare and Medicaid programs

H.R. 1393, Medicare Dental, Vision, and Hearing Benefit Act, 2019. H.R. 576, Seniors Have Eyes, Ears, and Teeth Act, 2019.

Client expense: $430,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Coverage of Dental Care: H.R. 576 and S. 22, Negotiation of Prescription Drug Prices: S. 99 and H.R. 448 and S. 62 and H.R. 275, Prescription Drug Importation: H.R. 447 and S. 97 and S. 61, Improving Access to Affordable Generics: S. 64.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Coverage of Dental Care: H.R. 576 and S. 22, Negotiation of Prescription Drug Prices: S. 99 and H.R. 448 and S. 62 and H.R. 275, Prescription Drug Importation: H.R. 447 and S. 97 and S. 61, Improving Access to Affordable Generics: S. 64.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Dental Benefit Act of 2019 (HR 2951/S. 22); Seniors Have Eyes, Ears, and Teeth Act (HR 576); Medicare Dental, Vision and Hearing Benefit Act of 2019 (HR 1393); Medicare Dental Act of 2019 (HR 4650); Lower Drug Costs Now Act (HR 3) Competitive Health Insurance Reform Act of 2019 (S. 350/HR 1418), Policies related to operation of the Affordable Care Act Exchanges, including enrollment functions and independent purchase of dental benefits. Policies related to operation of the Affordable Care Act Exchanges, including enrollment functions and independent purchase of dental benefits.

Client expense: $170,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, Treasury, Dept of

Medicare Dental Benefit Act of 2019 (HR 2951/S. 22); Seniors Have Eyes, Ears, and Teeth Act (HR 576); Medicare Dental, Vision and Hearing Benefit Act of 2019 (HR 1393); Medicare Dental Act of 2019 (HR 4650); Lower Drug Costs Now Act (HR 3) Health Insurance Tax Relief Act of 2019 (S 172/HR 1398) Competitive Health Insurance Reform Act of 2019 (S 350/HR 1418) DOC Access Act of 2019 (HR 3762), policies related to provider contracting Policies related to operation of the Affordable Care Act Exchanges, including enrollment functions and independent purchase of dental benefits.

Client expense: $170,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, Treasury, Dept of

H.R. 3 Lower Drug Costs Now Act of 2019 -allowing Medicare to negotiate prescription drug prices, limiting the ability of drug companies to spike their prices overnight, ensuring that actions to address egregious prices apply to coverage beyond Medicare S. 2543 Prescription Drug Pricing Reduction Act of 2019 - comprehensive legislation to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers H.AR. 4663 Freedom from Price Gouging Act - require drug manufacturers to pay a Medicare part B rebate for certain drugs if the price of such drugs increases faster than inflation. S. 64 Preserve Access to Affordable Generics and Biosimilars Act - prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products S.3092 Expanding Access to Low Cost Generics Act - Subjecting insulin to the new pathway to bring low-cost, generic insulin products to market S.2628 - Equity in Pretrial Medicaid Coverage Act of 2019 - remove a limitation on an individual's eligibility for medical assistance under the State Medicaid plan while the individual is in custody pending disposition of charges. H.R. 913 - CLINICAL TREAMENT Act - requires state Medicaid programs to cover routine patient costs for items and services that are provided in connection with a qualifying clinical trial regarding cancer or other life-threatening conditions Legislation to restore Medicaid eligibility to people from the Freely Associated States who are living in the U.S. under the terms of the Compacts of Free Association (COFA). H.R.1393 Medicare Dental, Vision, and Hearing Benefit Act of 2019 - provide for coverage of dental, vision, and hearing care under the Medicare program. H.R.576 Seniors Have Eyes, Ears, and Teeth Act - expands Medicare coverage to include eyeglasses, hearing aids, and dental care. S.22/H.R.2951 Medicare Dental Benefit Act of 2019 - coverage of dental services under Medicare Part B H.R.1342 EMPOWER Care Act - reauthorize the Money Follows the Person Demonstration Program H.R. 1343 - Protecting Married Seniors Act - provisions regarding Medicaid eligibility that protect against spousal impoverishment for recipients of home and community-based services. S.99 / H.R.448 - The Medicare Drug Price Negotiation Act - negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D H.R.1046 / S.377 Medicare Negotiation and Competitive Licensing Act of 2019 - requiring Secretary of Health and Human Services to negotiate prices of prescription drugs furnished under part D of the Medicare program H.R.4671 Helping Seniors Afford Health Care Act of 2019 - reduce cost-sharing, align income and resource eligibility tests, simplify enrollment, and provide for other program improvements for low-income Medicare beneficiaries. H.R. 4996 Helping Medicaid Offer Maternity Services Act of 2019 - MOMs Act - provide for a State option under the Medicaid program to provide for and extend continuous coverage for certain individual H.R.1329 Medicaid Reentry Act - allows Medicaid payment for medical services furnished to an incarcerated individual during the 30-day period preceding the individual's release H.R.1354 Territories Health Equity Act - make improvements to the treatment of the United States territories under the Medicare and Medicaid programs H.R.1384, S.1129 Medicare for All Act - establishes a national health insurance program Medicare Prescription Drug Savings and Choice Act - public option for drug coverage within Medicare Part D HEAL for Immigrant Women and Families Act of 2019 - Removes the five year waiting period for immigrants to become eligible for Medicaid and CHIP S.1423Medicare and Medicaid Dental, Vision, and Hearing Benefit Act of 2019 - provide for coverage of dental, vision, and hearing care under the Medicare and Medicaid programs S.1280BENES Act - establish a system to notify individuals approaching Medicare eligibility, to simplify and modernize the eligibility enrollment process

Medicare and Medicaid Dental, Vision, and Hearing Benefit Act of 2019 (S. 1423); Seniors Have Eyes, Ears, and Teeth Act (H.R. 576); Medicare Dental Benefit Act of 2019 (S. 22/H.R. 2951); Medicare Dental, Vision, and Hearing Benefit Act of 2019 (H.R. 1393); Medicare Dental Act of 2019 (H.R. 4650); Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3).

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 1393, Medicare Dental, Vision, and Hearing Benefit Act, 2019. H.R. 576, Seniors Have Eyes, Ears, and Teeth Act, 2019.

Client expense: $380,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Coverage of Dental Care: H.R. 576 and S. 22, Negotiation of Prescription Drug Prices: S. 99 and H.R. 448 and S. 62 and H.R. 275, Prescription Drug Importation: H.R. 447 and S. 97 and S. 61, Improving Access to Affordable Generics: S. 64.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Dental Benefit Act of 2019 (S. 22); Seniors Have Eyes, Ears, and Teeth Act (HR 576); Medicare Dental, Vision and Hearing Benefit Act of 2019 (HR 1393) Health Insurance Tax Relief Act of 2019 (S 172/HR 1398) Competitive Health Insurance Reform Act of 2019 (S 350/HR 1418) Lower Health Care Costs Act (S. 1895) Policies related to operation of the Affordable Care Act Exchanges, including enrollment functions and independent purchase of dental benefits.

Client expense: $120,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, Treasury, Dept of

Medicare Dental Benefit Act of 2019 (S. 22); Seniors Have Eyes, Ears, and Teeth Act (HR 576); Medicare Dental, Vision and Hearing Benefit Act of 2019 (HR 1393) Competitive Health Insurance Reform Act of 2019 (S 350/HR 1418), Policies related to operation of the Affordable Care Act Exchanges, including enrollment functions and independent purchase of dental benefits. Policies related to operation of the Affordable Care Act Exchanges, including enrollment functions and independent purchase of dental benefits. Lower Health Care Costs Act (S. 1895)

Client expense: $120,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, Treasury, Dept of

Medicare and Medicaid Dental, Vision, and Hearing Benefit Act of 2019 (S. 1423); Seniors Have Eyes, Ears, and Teeth Act (H.R. 576); Medicare Dental Benefit Act of 2019 (S. 22); Medicare Dental, Vision, and Hearing Benefit Act of 2019 (H.R. 1393).

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 3 Lower Drug Costs Now Act of 2019 -allowing Medicare to negotiate prescription drug prices, limiting the ability of drug companies to spike their prices overnight, ensuring that actions to address egregious prices apply to coverage beyond Medicare S. 2543 Prescription Drug Pricing Reduction Act of 2019 - comprehensive legislation to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers H.R. 3853 Personal Needs Allowance Modernization Act of 2019 - increase under the Medicaid program the minimum monthly personal needs allowance for institutionalized individuals and couples H.R.4386 Stop the Wait Act - eliminate the Medicare and disability insurance benefits waiting periods for disabled individuals. H.R.1393 Medicare Dental, Vision, and Hearing Benefit Act of 2019 - provide for coverage of dental, vision, and hearing care under the Medicare program. H.R.576 Seniors Have Eyes, Ears, and Teeth Act - expands Medicare coverage to include eyeglasses, hearing aids, and dental care. S.22/H.R.2951 Medicare Dental Benefit Act of 2019 - coverage of dental services under Medicare Part B H.R.1342 EMPOWER Care Act - reauthorize the Money Follows the Person Demonstration Program H.R. 1343 - Protecting Married Seniors Act - provisions regarding Medicaid eligibility that protect against spousal impoverishment for recipients of home and community-based services. S.99 / H.R.448 - The Medicare Drug Price Negotiation Act - negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D H.R.1046 / S.377 Medicare Negotiation and Competitive Licensing Act of 2019 - requiring Secretary of Health and Human Services to negotiate prices of prescription drugs furnished under part D of the Medicare program S.470 Medicare at 50 Act - option for any citizen or permanent resident of the United States age 50 to 64 to buy into Medicare H.R.1329 Medicaid Reentry Act - allows Medicaid payment for medical services furnished to an incarcerated individual during the 30-day period preceding the individual's release H.R.1354 Territories Health Equity Act - make improvements to the treatment of the United States territories under the Medicare and Medicaid programs H.R.1384, S.1129 Medicare for All Act - establishes a national health insurance program Medicare Prescription Drug Savings and Choice Act - public option for drug coverage within Medicare Part D HEAL for Immigrant Women and Families Act of 2019 - Removes the five year waiting period for immigrants to become eligible for Medicaid and CHIP H.R.2463, S.1261 Choose Medicare Act - establishment of Medicare part E public health plans S.1423Medicare and Medicaid Dental, Vision, and Hearing Benefit Act of 2019 - provide for coverage of dental, vision, and hearing care under the Medicare and Medicaid programs

H.R. 1393, Medicare Dental, Vision, and Hearing Benefit Act, 2019. H.R. 576, Seniors Have Eyes, Ears, and Teeth Act, 2019.

Client expense: $720,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Coverage of Dental Care: H.R. 576 and S. 22, Negotiation of Prescription Drug Prices: S. 99 and H.R. 448 and S. 62 and H.R. 275, Prescription Drug Importation: H.R. 447 and S. 97 and S. 61, Improving Access to Affordable Generics: S. 64.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Drug Pricing. H.R. 3, the Lower Drug Costs Now Act: Proposals to authorize the Secretary of Health and Human Services (HHS) to negotiate drug prices on behalf of Medicare with pharmaceutical manufactureres. Create a maximum price for any negotiated drug with an international price index (Average International Market price). Require drug manufacturers that refuse to negotiation with HHS to pay a Non-Compliance Fee of 65 percent of the gross sales of the drug in question. Require drug companies that raised the price of a drug in Medicare above the rate of inflation since 2016 to either lower the price or pay the entire price above inflation in a rebate back to the Treasury. Create a $2,000 Medicare beneficiary annual out-of-pocket cost cap for prescription drugs. Drug Pricing. S. 2543, the Prescription Drug Pricing Reduction Act of 2019: Require pharmaceutical manufacturers to rebate Medicare if they raise their prices for drugs covered by Medicare Parts B and D faster than inflation. Establish an out-of-pocket spending limit in which Medicare beneficiaries would pay no more than $3,100 a year on drug costs. Require Medicare Part D private insurers to pay 60 percent and, drug makers 20 percent, of the costs incurred over the out-of-pocket spending cap. Increase transparency into pharmacy benefit manager practices and manufacturer drug pricing decisions. Provide state Medicaid programs with more authority to contain drug prices. Drug Pricing. H.R. 1046, the Medicare Negotiation and Competitive Licensing Act: Proposal to allow the Secretary of Health and Human Services to directly negotiate prices for prescription drugs and issue a competitive license allowing other manufacturers to produce the drug for Medicare in the event negotiations fail. Drug Pricing. S. 1895, the Lower Health Care Costs Act of 2019: Proposals to reduce the cost of prescription drugs including allowing generic drug manufacturers to sue brand-name manufacturers for not selling them samples for testing necessary to get to market; and requiring a drug manufacturer to submit a report to the Secretary of Health and Human Services for each price increase of certain drugs of which the wholesale acquisition cost increase is equal to 10 percent or more over a 12-month period or 25 percent or moreover a 36-month period. Dementia and Alzheimers Disease. S. 2076/H.R. 4256, Building Our Largest Dementia Infrastructure for Alzheimers Act (BOLD Act): Proposal to apply a public health approach to combat Alzheimers disease and related dementias. Medicare Observation Status. H.R. 1682/S. 753, the Improving Access to Medicare Coverage Act of 2019: Proposal to count days in the hospital in observation status toward meeting the three-day prior hospitalization requirement for skilled nursing facility care eligibility. Generic Drug Introduction. Generic Drug Introduction. H.R. 965, the CREATES Act: Proposal to speed the introduction of generic competition by curbing brand drug maker abuses of safety procedures as a means to limit generic manufacturer access to the drug samples needed to obtain Food and Drug Administration approval. Health Care Rights Law. Proposed rule to the provision of the Affordable Care Act addressing discrimination based on age, race, color, national origin, English proficiency, disability or sex. Medicaid Home and Community-Based Services: H.R. 1839, the Medicaid Services Investment and Accountability Act of 2019: Proposal extending the spousal impoverishment protections for home and community-based services until September 2019. Medicare Prescription Drug Costs. (No bill.) Proposals to reduce amount drug manufacturers must contribute to closing the donut hole in 2019. Medicare Prescription Drug Costs. (No bill.) Provisions of the United States-Mexico-Canada Agreement (formerly the North American Free Trade Agreement) addressing countries having expansive regulatory approval monopolies for biologic drugs and restricting the ability of Congress to reform patent laws that drive up drug costs for Medicare. Medicare Coverage Expansion. H.R. 576, the Seniors Have Eyes, Ears, and Teeth Act of 2019; H.R. 1393, the Medicare Dental, Vision, and Hearing Benefit Act of 2019; H.R. 1518, the Medicare Hearing Aid Coverage Act of 2019: Proposals to expand Medicare coverage to include, vision, dental and hearing benefits. Medicare Open Enrollment. (No bill.) Proposals to ensure the Centers for Medicare and Medicaid Services conducts open enrollment in a way that is unbiased toward the traditional program. Medicare Part D. (No bill.) Proposals to add an out-of-pocket cap, rationalize the structure of the Part D program, and make the Part D low-income subsidy more generous. Medigap Reform: H.R. 1394, the Medigap Consumer Protection Act: Proposal to improve quality of coverage and access to Medigap by restoring first dollar coverage and extending guaranteed issue to disabled people and other beneficiairies. Drug Safety. S. 1895, the Lower Health Care Costs Act of 2019: Proposal to remove requirement that medicines marketed in the U.S. adhere to quality standards established by the U.S. Pharmacopeia. These standards allow biosimilar makers to achieve regulatory certainty and expedite biosimilars to market. Medicare Enrollment. H.R. 2477/S. 1280, the BENES Act of 2019: Proposal to improve beneficiary education tools and extend funding for state health insurance and assistance programs. Reducing Health Care Costs: S. 1895, the Lower Health Care Costs Act of 2019: Proposal to eliminate surprise medical billing including out-of-network charges in emergencies.

Drug Pricing. H.R. 3, the Lower Drug Costs Now Act: Proposals to authorize the Secretary of Health and Human Services (HHS) to negotiate drug prices on behalf of Medicare with pharmaceutical manufactureres. Create a maximum price for any negotiated drug with an international price index (Average International Market price). Require drug manufacturers that refuse to negotiation with HHS to pay a Non-Compliance Fee of 65 percent of the gross sales of the drug in question. Require drug companies that raised the price of a drug in Medicare above the rate of inflation since 2016 to either lower the price or pay the entire price above inflation in a rebate back to the Treasury. Create a $2,000 Medicare beneficiary annual out-of-pocket cost cap for prescription drugs. Drug Pricing. S. 2543, the Prescription Drug Pricing Reduction Act of 2019: Require pharmaceutical manufacturers to rebate Medicare if they raise their prices for drugs covered by Medicare Parts B and D faster than inflation. Establish an out-of-pocket spending limit in which Medicare beneficiaries would pay no more than $3,100 a year on drug costs. Require Medicare Part D private insurers to pay 60 percent and, drug makers 20 percent, of the costs incurred over the out-of-pocket spending cap. Increase transparency into pharmacy benefit manager practices and manufacturer drug pricing decisions. Provide state Medicaid programs with more authority to contain drug prices. Drug Pricing. H.R. 1046, the Medicare Negotiation and Competitive Licensing Act: Proposal to allow the Secretary of Health and Human Services to directly negotiate prices for prescription drugs and issue a competitive license allowing other manufacturers to produce the drug for Medicare in the event negotiations fail. Drug Pricing. S. 1895, the Lower Health Care Costs Act of 2019: Proposals to reduce the cost of prescription drugs including allowing generic drug manufacturers to sue brand-name manufacturers for not selling them samples for testing necessary to get to market; and requiring a drug manufacturer to submit a report to the Secretary of Health and Human Services for each price increase of certain drugs of which the wholesale acquisition cost increase is equal to 10 percent or more over a 12-month period or 25 percent or moreover a 36-month period. Dementia and Alzheimers Disease. S. 2076/H.R. 4256, Building Our Largest Dementia Infrastructure for Alzheimers Act (BOLD Act): Proposal to apply a public health approach to combat Alzheimers disease and related dementias. Medicare Observation Status. H.R. 1682/S. 753, the Improving Access to Medicare Coverage Act of 2019: Proposal to count days in the hospital in observation status toward meeting the three-day prior hospitalization requirement for skilled nursing facility care eligibility. Generic Drug Introduction. Generic Drug Introduction. H.R. 965, the CREATES Act: Proposal to speed the introduction of generic competition by curbing brand drug maker abuses of safety procedures as a means to limit generic manufacturer access to the drug samples needed to obtain Food and Drug Administration approval. Health Care Rights Law. Proposed rule to the provision of the Affordable Care Act addressing discrimination based on age, race, color, national origin, English proficiency, disability or sex. Medicaid Home and Community-Based Services: H.R. 1839, the Medicaid Services Investment and Accountability Act of 2019: Proposal extending the spousal impoverishment protections for home and community-based services until September 2019. Medicare Prescription Drug Costs. (No bill.) Proposals to reduce amount drug manufacturers must contribute to closing the donut hole in 2019. Medicare Prescription Drug Costs. (No bill.) Provisions of the United States-Mexico-Canada Agreement (formerly the North American Free Trade Agreement) addressing countries having expansive regulatory approval monopolies for biologic drugs and restricting the ability of Congress to reform patent laws that drive up drug costs for Medicare. Medicare Coverage Expansion. H.R. 576, the Seniors Have Eyes, Ears, and Teeth Act of 2019; H.R. 1393, the Medicare Dental, Vision, and Hearing Benefit Act of 2019; H.R. 1518, the Medicare Hearing Aid Coverage Act of 2019: Proposals to expand Medicare coverage to include, vision, dental and hearing benefits. Medicare Open Enrollment. (No bill.) Proposals to ensure the Centers for Medicare and Medicaid Services conducts open enrollment in a way that is unbiased toward the traditional program. Medicare Part D. (No bill.) Proposals to add an out-of-pocket cap, rationalize the structure of the Part D program, and make the Part D low-income subsidy more generous. Medigap Reform: H.R. 1394, the Medigap Consumer Protection Act: Proposal to improve quality of coverage and access to Medigap by restoring first dollar coverage and extending guaranteed issue to disabled people and other beneficiairies. Drug Safety. S. 1895, the Lower Health Care Costs Act of 2019: Proposal to remove requirement that medicines marketed in the U.S. adhere to quality standards established by the U.S. Pharmacopeia. These standards allow biosimilar makers to achieve regulatory certainty and expedite biosimilars to market. Medicare Enrollment. H.R. 2477/S. 1280, the BENES Act of 2019: Proposal to improve beneficiary education tools and extend funding for state health insurance and assistance programs. Reducing Health Care Costs: S. 1895, the Lower Health Care Costs Act of 2019: Proposal to eliminate surprise medical billing including out-of-network charges in emergencies.

H.R. 1393, Medicare Dental, Vision, and Hearing Benefit Act, 2019. H.R. 576, Seniors Have Eyes, Ears, and Teeth Act, 2019.

Client expense: $810,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Dental Benefit Act of 2019 (S. 22); Seniors Have Eyes, Ears, and Teeth Act (HR 576); Medicare Dental, Vision and Hearing Benefit Act of 2019 (HR 1393) Health Insurance Tax Relief Act of 2019 (S 172/HR 1398) Competitive Health Insurance Reform Act of 2019 (S 350/HR 1418) Lower Health Care Costs Act (S. 1895) Policies related to operation of the Affordable Care Act Exchanges, including enrollment functions and independent purchase of dental benefits.

Client expense: $150,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, Treasury, Dept of

Medicare Dental Benefit Act of 2019 (S. 22); Seniors Have Eyes, Ears, and Teeth Act (HR 576); Medicare Dental, Vision and Hearing Benefit Act of 2019 (HR 1393) Competitive Health Insurance Reform Act of 2019 (S 350/HR 1418), Policies related to operation of the Affordable Care Act Exchanges, including enrollment functions and independent purchase of dental benefits. Policies related to operation of the Affordable Care Act Exchanges, including enrollment functions and independent purchase of dental benefits. Lower Health Care Costs Act (S. 1895)

Client expense: $150,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, Treasury, Dept of

Medicare and Medicaid Dental, Vision, and Hearing Benefit Act of 2019 (S. 1423); Seniors Have Eyes, Ears, and Teeth Act (H.R. 576); Medicare Dental Benefit Act of 2019 (S. 22); Medicare Dental, Vision, and Hearing Benefit Act of 2019 (H.R. 1393).

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R.2757 Creating Lower Cost Alternative for Your (CLAY) Prescription Drug Act - would eliminate cost-sharing for generic drugs for low-income Medicare beneficiaries H.R.1393 Medicare Dental, Vision, and Hearing Benefit Act of 2019 - provide for coverage of dental, vision, and hearing care under the Medicare program. H.R.576 Seniors Have Eyes, Ears, and Teeth Act - expands Medicare coverage to include eyeglasses, hearing aids, and dental care. S.22 Medicare Dental Benefit Act of 2019 - coverage of dental services under Medicare Part B H.R.1342 EMPOWER Care Act - reauthorize the Money Follows the Person Demonstration Program H.R. 1343 - Protecting Married Seniors Act - provisions regarding Medicaid eligibility that protect against spousal impoverishment for recipients of home and community-based services. S.99 / H.R.448 - The Medicare Drug Price Negotiation Act - negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D H.R.1046 / S.377 Medicare Negotiation and Competitive Licensing Act of 2019 - requiring Secretary of Health and Human Services to negotiate prices of prescription drugs furnished under part D of the Medicare program S.470 Medicare at 50 Act - option for any citizen or permanent resident of the United States age 50 to 64 to buy into Medicare H.R.1329 Medicaid Reentry Act - allows Medicaid payment for medical services furnished to an incarcerated individual during the 30-day period preceding the individual's release H.R.1354 Territories Health Equity Act - make improvements to the treatment of the United States territories under the Medicare and Medicaid programs H.R.3215, S.1754 The Disaster Relief Medicaid Act - provide Medicaid assistance to individuals and families affected by a disaster or emergency H.R.1384, S.1129 Medicare for All Act - establishes a national health insurance program H.R.2477, S.1280 Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act - establish a system to notify individuals approaching Medicare eligibility, to simplify and modernize the eligibility enrollment process Medicare Prescription Drug Savings and Choice Act - public option for drug coverage within Medicare Part D H.R.2463, S.1261 Choose Medicare Act - establishment of Medicare part E public health plans S.1423 Medicare and Medicaid Dental, Vision, and Hearing Benefit Act of 2019 - provide for coverage of dental, vision, and hearing care under the Medicare and Medicaid programs

Drug Pricing. H.R. 1046, the Medicare Negotiation and Competitive Licensing Act: Proposal to allow the Secretary of Health & Human Services to directly negotiate prices for prescription drugs and issue a competitive license allowing other manufacturers to produce the drug for Medicare in the event negotiations fail. Medicare Observation Status. H.R. 1682/S. 753, Improving Access to Medicare Coverage Act of 2019: Proposal to count days in the hospital in observation status toward meeting the three-day prior hospitalization requirement for skilled nursing facility care eligibility. Dementia and Alzheimers Disease. S. 2076/H.R. 4256, Building Our Largest Dementia Infrastructure for Alzheimers Act (BOLD Act): Proposal to apply a public health approach to combat Alzheimers disease and related dementias. Generic Drug Introduction. H.R. 965, CREATES Act: Proposal to speed the introduction of generic competition by curbing brand drug maker abuses of safety procedures as a means to limit generic manufacturer access to the drug samples needed to obtain Food and Drug Administration approval. Medicaid Home and Community-Based Services: H.R. 1839, the Medicaid Services Investment and Accountability Act of 2019: Proposal extending the spousal impoverishment protections for home and community-based services until September 2019. Medicare Prescription Drug Costs. (No bill): Proposals to reduce amount drug manufacturers must contribute to closing the donut hole in 2019. Medicare Prescription Drug Costs. (No bill): Provisions of the United States-Mexico-Canada Agreement (formerly the North American Free Trade Agreement) addressing countries having expansive regulatory approval monopolies for biologic drugs and restricting the ability of Congress to reform patent laws that drive up drug costs for Medicare. Medicare Prescription Drug Costs. (No bill): Proposal to remove safe harbor from anti-kickback laws for drug rebates under Medicare Part D. Medicare Coverage Expansion. H.R. 576, the Seniors Have Eyes, Ears, and Teeth Act of 2019; H.R. 1393, the Medicare Dental, Vision, and Hearing Benefit Act of 2019; H.R. 1518, the Medicare Hearing Aid Coverage Act of 2019: Proposals to expand Medicare coverage to include, vision, dental and hearing. Medicare Open Enrollment. (No bill): Proposals to ensure the Centers for Medicare and Medicaid Services conducts open enrollment in a way that is unbiased toward the traditional program. Medicare Part D. (No bill): Proposals to add an out-of-pocket cap and rationalize the structure of the program. Medicare Part D. (No bill) Proposal to add a cap to the Part D benefit, maintain the manufacturer discount in the calculation of the threshold to enter the catastrophic benefit so that seniors need to pay less out-of-pocket to move through the donut hole, and streamline the Part D coverage determination and appeals process. Drug Pricing. (No bill): Proposals to reduce the cost of prescription drugs. Affordable Care Act Stabilization. H.R. 987, the Strengthening Health Care and Lowering Prescription Drug Costs Act: Proposal to reduce drug costs for Americans including seniors and to stabilize the Affordable Care Acts marketplaces. Medicare Enrollment. H.R. 2477/S. 1280, BENES Act of 2019: proposal to improve beneficiary education tools and extend funding for state health insurance and assistance(SHIP) programs.

Medicare Coverage of Dental Care: H.R. 576 and S. 22, Negotiation of Prescription Drug Prices: S. 99 and H.R. 448 and S. 62 and H.R. 275, Prescription Drug Importation: H.R. 447 and S. 97 and S. 61, Improving Access to Affordable Generics: S. 64.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1393, Medicare Dental, Vision, and Hearing Benefit Act, 2019. H.R. 576, Seniors Have Eyes, Ears, and Teeth Act, 2019.

Client expense: $330,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

(S. 22) Medicare Dental Benefit Act of 2019; (HR 576) Seniors Have Eyes, Ears, and Teeth Medicare Dental Benefit Act of 2019 (S. 22); Seniors Have Eyes, Ears, and Teeth Act (HR 576); Medicare Dental, Vision and Hearing Benefit Act of 2019 (HR 1393).

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicare Dental Benefit Act of 2019 (S. 22); Seniors Have Eyes, Ears, and Teeth Act (HR 576); Medicare Dental, Vision and Hearing Benefit Act of 2019 (HR 1393) Competitive Health Insurance Reform Act of 2019 (S 350/HR 1418), Policies related to operation of the Affordable Care Act Exchanges, including enrollment functions and independent purchase of dental benefits. Policies related to operation of the Affordable Care Act Exchanges, including enrollment functions and independent purchase of dental benefits.

Client expense: $110,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, Treasury, Dept of

Medicare Dental Benefit Act of 2019 (S. 22); Seniors Have Eyes, Ears, and Teeth Act (HR 576); Medicare Dental, Vision and Hearing Benefit Act of 2019 (HR 1393) Health Insurance Tax Relief Act of 2019 (S 172/HR 1398) Competitive Health Insurance Reform Act of 2019 (S 350/HR 1418), Policies related to operation of the Affordable Care Act Exchanges, including enrollment functions and independent purchase of dental benefits.

Client expense: $110,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, Treasury, Dept of

Drug Pricing. (No Bill): Proposals to eliminate rebates for drugs in Medicare Part D with the exception of drugs rebated to consumers at the point of sale. Drug Pricing. H.R. 1046, The Medicare Negotiation and Competitive Licensing Act: Proposal to allow the Secretary of Health and Human Services to negotiate prices directly for prescription drugs and to issue a competitive license allowing other manufacturers to produce a drug for Medicare in the event negotiations fail. Medicare Penalties. H.R. 1788, Medicare Part B Penalties Fairness Act: Proposal limiting the penalty for Part B late enrollment and to allow those with Consolidated Omnibus Budget Reconciliation Act (COBRA) coverage to avoid paying the penalty. Medicare Financing. (No Bill): Proposal to redirect the current tax assessment on net investment income to the Medicare Trust Fund. Opioid Treatment. (No Bill): The MORE Savings Act proposal to eliminate cost-sharing (including copayments, deductibles and coinsurance) for opioid treatment and recovery support services under private insurance plans and through a demonstration in Medicare, while providing increased funding for Medicaid programs to offer these services. Medicare Benefits. (No Bill): The Medicare and Medicaid Dental, Vision, and Hearing Benefit Act proposal to expand Part B benefits to include coverage of oral, vision, and hearing care, while providing for reasonable measures to facilitate implementation and contain costs. Medicare Dental, Vision, and Hearing Coverage. H.R. 576, Seniors Have Eyes, Ears and Teeth: Proposal to expand Medicare coverage to include comprehensive coverage of dental, vision, and hearing care. Hearing Aids. H.R. 1518, Medicare Hearing Aid Coverage Act: Proposal to provide Medicare coverage of hearing aids. Dental Benefits. S. 22, Medicare Dental Benefit Act: Proposal to make dental services a covered benefit under Medicare. Medicare Part D. S. 691, Medicare Extra Rx HELP Act: Proposal to eliminate the asset test, streamline program administration and to extend full benefits to individuals up to 200% of poverty for the low income subsidy program for Medicare Part D. Medicare Observation Status. H.R. 1682/S. 753, Improving Access to Medicare Coverage Act of 2019: Proposal to count days in the hospital in observation status toward meeting the three-day prior hospitalization requirement for skilled nursing facility care eligibility. Dementia and Alzheimers Disease. Building Our Largest Dementia Infrastructure for Alzheimers Act (BOLD Act): Proposal to apply a public health approach to combat Alzheimers disease and related dementias. Generic Drug Introduction. H.R. 965, CREATES Act: Proposal to speed the introduction of generic competition by curbing brand drug maker abuses of safety procedures as a means to limit generic manufacturer access to the drug samples needed to obtain Food and Drug Administration approval. Medicare Beneficiary Equitable Relief. (No Bill): Efforts to extend and make permanent the Centers for Medicare and Medicaid Services policy for equitable relief for select individuals currently or previously enrolled in Affordable Care Act Marketplace plans who delayed Medicare enrollment during their Initial Enrollment Period or during a qualifying Special Enrollment Period. Home and Community Based Long-Term Care. H.R. 1839, Medicaid Services Investment and Accountability Act of 2019: Proposal extending the spousal impoverishment protections for home and community based services until September 30th and provides $20 million in additional funding for the Medicaid Money Follows the Person (MFP) program. Medicare Prescription Drug Costs. (No Bill): Proposals to reduce amount drug manufacturers must contribute to closing the donut hole in 2019. Medicare Prescription Drug Costs. (No Bill): Provisions of the United States-Mexico-Canada Agreement (formerly the North American Free Trade Agreement) addressing countries having expansive regulatory approval monopolies for biologic drugs and restricting the ability of Congress to reform patent laws that drive up drug costs for Medicare. Medicare Part B Drug Costs. (No Bill): Proposals to reduce Medicare Part B drug costs by limiting Medicare payment when a drug price increase exceeds an inflation limit. Medicare Open Enrollment. (No Bill): Proposals to ensure the Centers for Medicare and Medicaid Services conducts open enrollment in a way that is unbiased toward the traditional program. Medicaid Expansion. S. 585, States Achieve Medicaid Expansion (SAME) Act: Proposal to provide a higher level of federal Medicaid funding for states that did not expand Medicaid when the Affordable Care Act was launched in 2014.

Medicare Coverage of Dental Care: H.R. 576 and S. 22, Negotiation of Prescription Drug Prices: S. 99 and H.R. 448 and S. 62 and H.R. 275, Prescription Drug Importation: H.R. 447 and S. 97 and S. 61, Improving Access to Affordable Generics: S. 64.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE